SOFIA (Bulgaria), November 30 (SeeNews) - Bulgarian medical consumables producer Etropal [BUL:ETR] said it recorded a non-consolidated net loss of 2.25 million levs ($1.3 million/1.15 million euro) in the first nine months of 2021, excluding minority interest, compared to a net profit of 32,000 levs in the same period of last year.
Etropal's total revenue went up to 6.5 million levs in the January-September from some 5.5 million levs in the comparable period of 2020, the company said in an interim financial statement on Monday.
Expenses increased to 8.7 million levs in the review period from 5.5 million levs a year earlier, mostly due to changes in inventories and balance costs of sold assets.
The company's assets fell to 11.8 million levs at the end of September from 13.2 million levs at the end of last year, due to a decline in production.
Etropal is specialised in the production of consumables for hemodialysis.
As at 16:25 CET on Tuesday, Etropal shares traded flat at 5.80 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)